Lalwani Nikhil
Reporting owner on Forms 3, 4 and 5, CIK 1822629.
Lalwani Nikhil reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-18.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ANIP · ANI PHARMACEUTICALS INCCIK 1023024 | director, officer (PRESIDENT & CEO) | 2 | 2026-11-18 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ANIP · ANI PHARMACEUTICALS INCCommon Stock | 2026-11-18 | S sold | -4,082 | $71.16 | 328,289 | Form 4 |
| ANIP · ANI PHARMACEUTICALS INCCommon Stock | 2026-11-16 | S sold | -1,318 | $71.4 | 332,371 | Form 4 |
| ANIP · ANI PHARMACEUTICALS INCCommon Stock | 2026-10-15 | S sold | -5,400 | $71.89 | 333,689 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001822629-26-000020 | ANI PHARMACEUTICALS INC | 2026-11-18 | ||
| Form 4 0001822629-26-000018 | ANI PHARMACEUTICALS INC | 2026-10-16 |